Insight

Environment in 2016: Reverse engineering the ecosystem

Environment in 2016: Reverse engineering the ecosystem

Heavy hitters from the drug development industry discuss investment cycles, drug market conditions, and dealmaking projections through 2016.

First-in-class "GlycoCAR" works for solid tumors and leukemia

First-in-class "GlycoCAR" works for solid tumors and leukemia


Jul 21, 2016

A new anticancer immunotherapy using chimeric antigen receptor (CAR) T-cells has been developed at University of Pennsylvania, targeting tumors as well as blood-borne cancer cells.

AZ BioVentureHub CEO says aim is an innovative ecosystem

AZ BioVentureHub CEO says aim is an innovative ecosystem


Jun 21, 2016

AstraZeneca’s BioVentureHub CEO explains the exchange's vision to generate a climate of open innovation to help grow and nurture the Scandinavian life science ecosystem.

partnering360®: leverage and cultivate your dealmaker network

partnering360 is the network for dealmakers in the life science industry. This global community of more than 34,000 is constantly growing, and the partnering opportunities continually updating.